Catalyst Wire Dossier Catalyst Wire Dossier

Low Dose IL-2 Therapy

Interleukin-2
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Low Dose IL-2 Therapy, covering 2026-04-06 to 2026-04-06. Get the full timeline:

Most recent: Clinical Trial Update: Low Dose IL-2 Therapy in Patients With a Depressive Episode in the Course of a Bipolar Disorder [Phase 2]

See pricing